Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Minguez

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
BMC Systems Biology|October 26, 2014
Understanding disease mechanisms with models of signaling pathway activitiesPatricia Sebastian-Leon, Enrique Vidal, Pablo Minguez, et al.
Nucleic Acids Research|December 4, 2012
STRING v9.1: protein-protein interaction networks, with increased coverage and integrationAndrea Franceschini, Damian Szklarczyk, Sune Frankild, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2016
Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trialAlfonso Gomez-Iturriaga, Francisco Casquero, Arantza Urresola, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2022
An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine, Jean-Pierre Pouget, Mark Konijnenberg, et al.
Journal of Contemporary Brachytherapy|May 24, 2021
Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer controlEsther Mayrata, Jose Maria Espinosa, David Büchser, et al.
Nucleic Acids Research|November 4, 2010
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scoredDamian Szklarczyk, Andrea Franceschini, Michael Kuhn, et al.
Plos Computational Biology|March 28, 2017
Systematic identification of phosphorylation-mediated protein interaction switchesMatthew J Betts, Oliver Wichmann, Mathias Utz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2020
Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trialAlfonso Gomez-Iturriaga, David Buchser, Esther Mayrata, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 14, 2022
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligandsKatarina Sjögreen Gleisner, Nicolas Chouin, Pablo Minguez Gabina, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed dosesJean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
BMC Systems Biology|October 26, 2014
Understanding disease mechanisms with models of signaling pathway activitiesPatricia Sebastian-Leon, Enrique Vidal, Pablo Minguez, et al.
Nucleic Acids Research|December 4, 2012
STRING v9.1: protein-protein interaction networks, with increased coverage and integrationAndrea Franceschini, Damian Szklarczyk, Sune Frankild, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2016
Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trialAlfonso Gomez-Iturriaga, Francisco Casquero, Arantza Urresola, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2022
An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine, Jean-Pierre Pouget, Mark Konijnenberg, et al.
Journal of Contemporary Brachytherapy|May 24, 2021
Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer controlEsther Mayrata, Jose Maria Espinosa, David Büchser, et al.
Nucleic Acids Research|November 4, 2010
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scoredDamian Szklarczyk, Andrea Franceschini, Michael Kuhn, et al.
Plos Computational Biology|March 28, 2017
Systematic identification of phosphorylation-mediated protein interaction switchesMatthew J Betts, Oliver Wichmann, Mathias Utz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2020
Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trialAlfonso Gomez-Iturriaga, David Buchser, Esther Mayrata, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 14, 2022
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligandsKatarina Sjögreen Gleisner, Nicolas Chouin, Pablo Minguez Gabina, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed dosesJean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.
Pageof 9